Biomark Diagnostics Inc. (CSE:BUX)
Canada
· Delayed Price · Currency is CAD 0.475
-0.005 (-1.04%)
At close: Dec 5, 2025
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 6.87K CAD in the quarter ending September 30, 2025, a decrease of -82.08%. This brings the company's revenue in the last twelve months to 123.42K, down -21.89% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.
Revenue (ttm)
123.42K
Revenue Growth
-21.89%
P/S Ratio
376.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.44M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| Green Thumb Industries | 1.61B |
| dentalcorp Holdings | 1.66B |
| Sienna Senior Living | 967.05M |
| Extendicare | 1.59B |
| Trulieve Cannabis | 1.66B |
| Cronos Group | 184.36M |
| WELL Health Technologies | 1.25B |